# Mechanical Ventilation Liberation

Liberate invasive ventilation through a daily, coordinated readiness assessment: reverse the indication for intubation, minimize sedation, perform a spontaneous breathing trial, then separately judge airway protection, secretion clearance, and need for prophylactic post-extubation support.

**Clinical question:** Which criteria support safe liberation from invasive mechanical ventilation, and what should change management after an unsuccessful trial?

Updated: 2026-09-15T20:59:37.263615+00:00

## What matters in practice
- Use a daily coordinated spontaneous awakening trial and spontaneous breathing trial pathway rather than waiting for arbitrary reductions in ventilator settings. [18]
- A passed spontaneous breathing trial establishes tolerance of unsupported breathing but does not establish safe extubation; separately assess airway protection and secretion clearance. [18]
- After spontaneous breathing trial failure, identify and treat the reversible mechanism, then reassess the next day rather than continuing an unstructured weaning process. [18]
- For patients at elevated risk of post-extubation respiratory failure, plan prophylactic noninvasive positive-pressure ventilation or high-flow nasal cannula rather than treating failure after it occurs. [4][5]
- In cardiac ICU patients, liberation can precipitate weaning-induced pulmonary edema because removal of invasive positive-pressure ventilation changes hemodynamic loading conditions. [5]

## When to initiate a liberation assessment

Assess daily once the acute indication for invasive ventilation is improving.

Use a coordinated daily spontaneous awakening trial (SAT) and spontaneous breathing trial (SBT) protocol to identify patients who can resume spontaneous breathing as early as possible. Protocolized daily assessment is preferred to passive reduction of ventilator support because the decision point is whether the patient can sustain spontaneous breathing, not whether a preset ventilator setting has been reached. [18][20]

The SBT should begin only when the clinical process that required intubation has improved sufficiently that spontaneous breathing may provide adequate gas exchange. In cardiogenic shock, apparent respiratory readiness may occur early while clinicians defer SATs or SBTs because of tachycardia, arrhythmias, or hemodynamic concern; explicitly reassess whether those abnormalities are prohibitive versus monitorable during a trial. [6][20]

Coordinate sedation interruption with the SBT when safe. Sedation-minimization protocols and paired SAT/SBT workflows are central components of adult liberation guidance, and daily paired trials have been associated with shorter duration of mechanical ventilation. [5][17][18]
- Before an SBT, confirm that the precipitating respiratory, neurologic, or hemodynamic problem is improving and that the patient can be evaluated without ongoing deep sedation. [18][20]
- In cardiogenic shock or other cardiac critical illness, anticipate that removing positive-pressure ventilation may unmask adverse cardiac loading conditions rather than assuming an SBT failure is purely pulmonary. [5]
- Do not substitute progressive lowering of ventilator support for a formal SBT; spontaneous breathing is the defining physiologic test for discontinuing ventilatory support. [20]

*Daily liberation sequence and the decision each step answers. [18][20]*

| Step | Clinical question | Action if unsuccessful | Action if successful |
| --- | --- | --- | --- |
| SAT | Can sedation be safely reduced enough to assess neurologic function and spontaneous effort? | Address the reason sedation interruption is unsafe; reassess with the next daily liberation screen. [18] | Proceed to SBT assessment. [18] |
| SBT | Can the patient sustain spontaneous breathing with adequate gas exchange? | Identify and treat the mechanism of failure; repeat assessment the next day. [18] | Perform a separate extubation-readiness assessment. [18] |
| Extubation assessment | Can the patient protect the airway and clear secretions after tube removal? | Continue invasive airway support despite an SBT pass if airway protection or secretion clearance is inadequate. [18] | Extubate, selecting planned post-extubation support according to risk and contraindications. [3][4][5] |

## How to interpret the spontaneous breathing trial

Use the SBT to test ventilatory independence, then avoid overinterpreting it.

An SBT is the principal test of readiness to discontinue ventilatory support and may be performed with a T-piece or pressure-support-based approach. Adult liberation guidance specifically addresses inspiratory pressure augmentation during SBTs, while comparative literature recognizes both T-piece and pressure-support strategies. [5][7][18][21]

A successful SBT answers whether the patient can breathe spontaneously; it does not prove that extubation will succeed. Higher measured work of breathing at the end of an otherwise successful SBT did not predict extubation failure in one study, so do not use that isolated finding to override a completed trial. [19]

Do not rely on the rapid shallow breathing index (RSBI) as a stand-alone extubation decision. The literature identifies the SBT as the best-validated approach to ventilator discontinuation, whereas the RSBI is a proposed predictor rather than a substitute for an SBT and airway assessment. [23][18]

For difficult-to-wean adults, both 30-minute and 120-minute SBT durations are studied approaches; select a standardized local method and interpret trial intolerance in the context of the mechanism causing failure rather than repeating serial trials within the same day without a corrective intervention. [7][18]
- Document the SBT method and whether the patient sustained spontaneous breathing; this permits meaningful comparison of repeated attempts. [7][18]
- After an SBT pass, move directly to airway, secretion, and post-extubation-support decisions rather than treating the SBT as the final clearance step. [18]
- After an SBT failure, avoid an automatic prolonged wean; define the reversible barrier before the next-day trial. [18]

### Cardiac patients

In cardiac ICU patients, an SBT increases the physiologic demand of unsupported breathing and removes the favorable hemodynamic effects of invasive positive-pressure ventilation. This transition can precipitate weaning-induced pulmonary edema; consider cardiac dysfunction when a patient develops respiratory intolerance during liberation despite improving lung mechanics. [5]

In a cardiogenic-shock cohort, only 22% underwent SBT within 48 hours and documented delays commonly reflected hemodynamic derangements or tachyarrhythmias, despite many patients receiving low-level ventilator support by 24 hours. Use serial bedside reassessment rather than ventilator settings alone to decide when hemodynamic risk permits testing. [6]

*What an SBT result does—and does not—establish. [18][19][20][23]*

| Finding | Interpretation | Next decision |
| --- | --- | --- |
| SBT not attempted | The patient has not yet undergone the required physiologic assessment of spontaneous breathing. [18][20] | Address the barrier to SAT/SBT eligibility and repeat the daily screen. [18] |
| SBT unsuccessful | Current ventilatory reserve is insufficient for liberation. [18][20] | Identify and treat the cause of trial failure; reassess the next day. [18] |
| SBT successful | The patient tolerated spontaneous breathing during the trial. [18] | Assess airway protection and secretion clearance before extubation; select prophylactic support when indicated. [18][4][5] |
| High end-SBT work of breathing alone | This isolated measurement did not predict extubation failure after a successful SBT. [19] | Do not use it alone to deny extubation; complete the airway and secretion assessment. [19][18] |

## Criteria beyond a passed breathing trial

Extubation requires readiness for both unsupported breathing and loss of the artificial airway.

After a successful SBT, evaluate whether the patient can protect the airway and clear secretions; these are explicit prerequisites to extubation and are not measured by ventilatory tolerance alone. Retain the endotracheal tube when either function is inadequate, even if the patient passed the SBT. [18]

Assess secretion burden and cough effectiveness at the bedside as extubation-specific risks. Secretion burden is commonly included in pediatric extubation-readiness bundles, and cough strength and secretions have been studied as determinants of extubation outcome among patients who have passed an SBT. [10][12]

Use a cuff-leak assessment when concern for post-extubation upper-airway obstruction changes management. Air-leak testing is included in adult liberation guidance and commonly incorporated into pediatric readiness bundles; its role is risk stratification for post-extubation stridor, not confirmation of lower-respiratory readiness. [7][12][18]

Patients with traumatic intubation, intubation longer than 6 days, a large endotracheal tube, female sex, or reintubation after unplanned extubation have recognized risk factors for post-extubation upper-airway complications. In these patients, incorporate the airway-risk assessment into the extubation plan rather than relying solely on the SBT result. [4]
- Pass SBT plus intact airway protection and secretion clearance: proceed to planned extubation. [18]
- Pass SBT but inadequate airway protection or inability to clear secretions: defer extubation and correct the limiting problem before repeat assessment. [18]
- Concern for upper-airway edema or stridor risk: add cuff-leak assessment to the pre-extubation decision. [7][12][18]

*Extubation decision after a successful SBT. [18][4][7][10][12]*

| Domain | Decision discriminator | Management implication |
| --- | --- | --- |
| Ventilatory capacity | Successful SBT. [18] | Proceed to extubation-specific assessment; an SBT pass alone is insufficient. [18] |
| Airway protection | Ability to protect the airway after tube removal. [18] | If inadequate, do not extubate solely because the SBT was passed. [18] |
| Secretion clearance | Bedside cough effectiveness and secretion burden. [10][12][18] | If clearance is inadequate, retain invasive airway support and reassess after addressing the barrier. [18] |
| Upper-airway risk | Cuff-leak assessment when post-extubation obstruction risk is clinically relevant. [7][12][18] | Plan for post-extubation airway surveillance and avoid treating a passed SBT as clearance of laryngeal risk. [4][18] |

## What to do when an SBT or extubation fails

Failure should trigger a mechanism-based correction, not an indefinite reduction in support.

When an SBT fails, identify and treat the reason for failure, then repeat the liberation assessment the next day. This approach distinguishes a transient or correctable barrier from persistent inability to sustain spontaneous ventilation and prevents delays created by unstructured weaning. [18]

For cardiac patients with respiratory distress during an SBT, evaluate for weaning-induced pulmonary edema because withdrawal of invasive positive-pressure ventilation can increase adverse hemodynamic stress. The actionable next step is to determine whether cardiac loading conditions, rather than unresolved primary lung disease alone, explain trial intolerance. [5]

Consider ventilator-associated diaphragm dysfunction in difficult or prolonged weaning. Mechanical ventilation can produce acute diaphragmatic atrophy and injury, diaphragm dysfunction is prevalent among mechanically ventilated patients, and it is a major contributor to difficult weaning. [13][14][16]

Continue to distinguish SBT failure from extubation failure. Extubation failure can occur after a successful trial because of airway obstruction, impaired protection, or secretion clearance failure; therefore, its prevention requires an airway-focused assessment and an appropriate post-extubation support plan rather than simply changing the next SBT. [18][4]
- SBT failure: correct the identified respiratory, cardiac, neurologic, sedation-related, or diaphragmatic barrier before the next-day trial. [18][5][13][16]
- Extubation failure after an SBT pass: reassess airway patency, airway protection, secretion clearance, and the appropriateness of planned post-extubation support. [18][4]
- Avoid delayed reintubation when post-extubation respiratory failure develops; close monitoring and prompt reintubation are specified components of the liberation pathway. [18]

*Mechanism-directed response to liberation failure. [18][5][13][14][16]*

| Failure pattern | Likely actionable branch | Next step |
| --- | --- | --- |
| SBT intolerance in cardiac critical illness | Weaning-induced pulmonary edema or other adverse hemodynamic response to removal of positive-pressure ventilation. [5] | Reassess cardiac loading conditions and treat the identified cardiac barrier before repeat testing. [5][18] |
| Repeated difficult SBTs | Diaphragm dysfunction or ICU-acquired weakness. [13][14][16] | Evaluate for neuromuscular/diaphragmatic contribution and avoid unnecessarily prolonged controlled ventilation. [13][14][16] |
| Post-extubation failure despite SBT pass | Airway protection, secretion clearance, upper-airway, or post-extubation respiratory-support failure. [18][4] | Monitor closely and reintubate promptly when respiratory failure requires it; revise the next extubation plan. [18] |

## Selecting post-extubation respiratory support

Use prophylactic support for selected patients rather than waiting for post-extubation deterioration.

After extubation, monitor closely for respiratory failure and need for prompt reintubation. In a multicenter cardiac ICU registry, reintubation occurred in 7.6% at a median of 2 days; extubation failure has been associated with mortality rates exceeding 50%, although it may also mark greater baseline illness severity. [4][18]

For patients at elevated risk of extubation failure, consider planned noninvasive positive-pressure ventilation (NIPPV) or high-flow nasal cannula (HFNC) immediately after extubation. Adult liberation guidance supports noninvasive ventilation immediately after extubation in appropriate patients, and cardiac ICU guidance recommends reserving prophylactic support for populations most likely to benefit when resources are constrained. [5][4]

Prefer planned NIV when acute COPD exacerbation or suspected hypercapnia is the relevant post-extubation phenotype, provided the patient can cooperate and protect the airway. HFNC is a practical alternative for patients without suspected hypercapnia, for those unable to tolerate NIV, and when NIV is contraindicated. [3]

Do not use NIV in patients with facial or cranial trauma or surgery, recent gastric or esophageal surgery, inability to protect the airway, active emesis or upper gastrointestinal bleeding, excessive secretions, or lack of cooperation. These contraindications direct the choice toward HFNC or another airway strategy, not a trial of poorly tolerated NIV. [3]
- Acute COPD exacerbation or suspected hypercapnia after extubation: plan NIV if airway protection, cooperation, and tolerance are present. [3]
- No suspected hypercapnia: HFNC is a protocolized post-extubation option. [3]
- NIV contraindication, intolerance, or excessive secretions: use HFNC when otherwise suitable and maintain close surveillance for reintubation. [3][18]
- Any post-extubation respiratory failure: act promptly on deterioration; supportive device selection must not delay needed reintubation. [18]

*Post-extubation support selection. [3][4][5][18]*

| Clinical situation | Preferred planned support | Key restriction |
| --- | --- | --- |
| Acute COPD exacerbation or suspected hypercapnia | NIV/NIPPV immediately after extubation when appropriate. [3][5] | Do not use NIV when airway protection, cooperation, secretion management, or surgical contraindications are inadequate. [3] |
| No suspected hypercapnia | HFNC is a protocolized post-extubation option. [3] | Continue close monitoring; HFNC does not replace prompt reintubation for progressive respiratory failure. [18] |
| NIV contraindicated or not tolerated | HFNC when otherwise appropriate. [3] | Contraindications include facial/cranial trauma or surgery, recent gastric/esophageal surgery, inability to protect the airway, active emesis or upper GI bleeding, excessive secretions, and lack of cooperation. [3] |
| High-risk cardiac ICU patient | Consider prophylactic NIPPV or HFNC. [4] | Allocate prophylactic support to patients expected to derive benefit when device availability is limited. [4] |

## References
1. The I-READI Quality and Safety Framework — catalyst.nejm.org — https://catalyst.nejm.org/doi/pdf/10.1056/CAT.20.0305
2. Proportional-Assist Ventilation for Minimizing the Duration ... — www.nejm.org — https://www.nejm.org/doi/abs/10.1056/NEJMoa2505708
3. Protocolized Post-Extubation Respiratory Support to prevent reintubation: protocol and statistical analysis plan for a clinical trial | BMJ Open — bmjopen.bmj.com — https://bmjopen.bmj.com/content/9/8/e030476
4. Liberation From Mechanical Ventilation in the Cardiac Intensive ... — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacadv.2022.100173
5. Positive Pressure Ventilation in the Cardiac Intensive Care Unit | JACC — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2018.06.074
6. Management Patterns and Outcomes of Invasive Mechanical Ventilation in Patients With Cardiogenic Shock — www.jacc.org — https://www.jacc.org/doi/full/10.1016/j.jacadv.2025.101916
7. Short (30 Minutes) versus long (120 Minutes) spontaneous breathing trial among patients with difficult weaning (SL-SBT Trial) - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0147956324002000
8. Improved Extubation Rates and Earlier Liberation from Mechanical Ventilation with Implementation of a Daily Spontaneous-Breathing Trial Protocol - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1072751507015979
9. Weaning from mechanical ventilation in neurocritical care — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0035378721007037
10. Cough strength, secretions and extubation outcome in burn patients who have passed a spontaneous breathing trial - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S030541791200321X
11. A spontaneous breathing trial with pressure... : Pediatric Critical Care Medicine — journals.lww.com — https://journals.lww.com/pccmjournal/fulltext/2011/11000/a_spontaneous_breathing_trial_with_pressure.29.aspx
12. Pediatric Ventilation Liberation: A Survey of... : Critical Care Explorations — journals.lww.com — https://journals.lww.com/ccejournal/fulltext/10.1097/cce.0000000000000756~pediatric-ventilation-liberation-a-survey-of-international
13. Temporary Transvenous Diaphragm Neurostimulation for Weaning ... — academic.oup.com — https://academic.oup.com/ajrccm/article/212/1/86/8435765
14. Lung- and Diaphragm-Protective Ventilation - Oxford Academic — academic.oup.com — https://academic.oup.com/ajrccm/article/202/7/950/8495441
15. Volume 209, Issue Supplement_1, May 2024 - Oxford Academic — academic.oup.com — https://academic.oup.com/ajrccm/issue/209/Supplement_1
16. Weakness acquired in the cardiac intensive care unit — academic.oup.com — https://academic.oup.com/ehjacc/article/14/2/107/7932194
17. Timing of Spontaneous Awakening and Breathing Trial Affects Duration of Mechanical Ventilation - CHEST — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(16)56529-5/fulltext
18. [PDF] Clinical Care for Severe Acute Respiratory Infection Toolkit - IRIS — iris.who.int — https://iris.who.int/server/api/core/bitstreams/3d03d529-ed0f-456e-bc40-fd7bdf0bcb4a/content
19. Higher Work of Breathing at the End of Successful Spontaneous Breathing Trial Does Not Predict Extubation Failure - CHEST — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(16)56516-7/fulltext
20. WEANING AND EXTUBATION READINESS IN PEDIATRIC PATIENTS — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849975
21. Effect of Protocolized Weaning and Spontaneous Breathing Trial vs Conventional Weaning on Duration of Mechanical Ventilation: A Randomized Controlled Trial - PubMed — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pubmed/34963728
22. Simulation-based Assessment to Measure Proficiency in ... — www.atsjournals.org — https://www.atsjournals.org/doi/pdf/10.34197/ats-scholar.2021-0130OC
23. Analysis of Rapid Shallow Breathing Index as a Predictor for Successful Extubation from Mechanical Ventilation - CHEST — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(16)46523-2/fulltext
24. Intubation and mechanical ventilation of the asthmatic ... — www.jacionline.org — https://www.jacionline.org/article/S0091-6749(09)00796-9/fulltext

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.